September 05.2010
 CTQJPH CHINESE
 
  Home　|　About Us　|　Products　|　New & Support　|　International Trade　|　Contact Us
 
　 Pharmaceutical Intermediates
Pharmaceutical Intermediates
Capecitabine intermediate K4
Capecitabine Intermediate K45
Gemcitabine HCl intermediateT3
Gemcitabine HCl intermediateT6
Gemcitabine HCl intermediateT8
Gemcitabine HCl IntermediateT9
Febuxostat Intermediate T1
Febuxostat Intermediate T2
Febuxostat Intermediate T3
Febuxostat Intermediate T4
Febuxostat Intermediate T5
　 APIs
APIs
Capecitabine
Gemcitabine Hydrochloride
Risedronate Sodium
Altretamine
Febuxostat
Allicin Oil
　 Finished Dosage
Cefixime Tablets
Cefaclor Tablets
Cefaclor Suspension
Cefaclor and Bromhexine Hydroc
Cefaclor and Bromhexine Hydroc
Terramycin Tablets
Meleucamycin Tablets
Glucosamine Hydrochloride Tabl
Altretamine Capsule
Home > Product > Febuxostat
 
Febuxostat
Febuxostat
 
Brief Introduction:

Febuxostat is an inhibitor of xanthine oxidase that is indicated for use in the treatment of hyperuricemia and gout.
 
Product Specification:

Product Name: Febuxostat
Systematic (IUPAC) name:

2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid
CAS number: 144060-53-7
Molecular Formula: C16H16N2O3S
Molecular Weight: 316.37
Shape: Off-white to white powder

 
Relative Products in the group of ANTINEOPLASTIC Agents:
 
Home | FAQ
Copyright © 2008 JIANGSU CHIATAI QINGJIANG PHARMACEUTICAL CO.,LTD. All rights reserved.
Tel: 086-025-68551657　Fax: 086-025-68551658　E-Mail: cphi@ctqjpharm.com